CRISPR Therapeutics AG (CRSP)

Industry Biotechnology

This stock can be held in an Investment ISA and an Investment Account

Sell

$55.40

Buy

$55.51

arrow-up$0.88 (+1.61%)

Prices updated at 01 Jul 2026, 18:48 EDT

Prices minimum 15 mins delay

Prices in USD

Crispr Therapeutics is a gene editing company focused on the development of Crispr/Cas9-based therapeutics. Crispr/Cas9 stands for clustered regularly interspaced short palindromic repeats (Crispr)/Crispr-associated protein 9 (Cas9), which is a revolu ...

NASDAQ

-0.3%

NASDAQ

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

our Investment Fees and Charges.

	$57.25 - $54.56
	$78.48 - $44.12
	-
	5,371.32m
	-
	-
	526,232
	2.96
	2,265,476.68
	3.16
	96.01m
	CH0334081137
	-6.17
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.